These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C. Ogawa E, Furusyo N, Shimizu M, Ihara T, Hayashi T, Harada Y, Toyoda K, Murata M, Hayashi J. Antivir Ther; 2015; 20(2):185-92. PubMed ID: 24941012 [Abstract] [Full Text] [Related]
3. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment. El Raziky M, Attia D, El Akel W, Shaker O, Khatab H, Abdo S, Elsharkawy A, Esmat G. Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736 [Abstract] [Full Text] [Related]
11. Fibro-indices versus liver stiffness for prediction of significant fibrosis in hepatitis B virus-infected Egyptian patients; a single-center experience. Said M, Eletreby R, Omar H, Dabees H, Abdelghafour R, El-Serafy M, Doss W. Expert Rev Gastroenterol Hepatol; 2020 Mar; 14(3):221-227. PubMed ID: 32031424 [Abstract] [Full Text] [Related]
12. Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy. Esmat GE, Al Akel W, Abdel Aziz RA, Al Sayed Taha A, Sabry D, Rashed LA, Mostafa A, El Kazaz AY, Ahmed SH. J Interferon Cytokine Res; 2016 Mar; 36(3):149-58. PubMed ID: 26982165 [Abstract] [Full Text] [Related]
15. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE. Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455 [Abstract] [Full Text] [Related]
16. Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C. de Oliveira AC, El-Bacha I, Vianna MV, Parise ER. Ann Hepatol; 2016 Jun; 15(3):326-32. PubMed ID: 27049486 [Abstract] [Full Text] [Related]
18. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients. Omran D, Zayed RA, Nabeel MM, Mobarak L, Zakaria Z, Farid A, Hassany M, Saif S, Mostafa M, Saad OK, Yosry A. Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460 [Abstract] [Full Text] [Related]
19. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin. Ng KJ, Tseng CW, Chang TT, Tzeng SJ, Hsieh YH, Hung TH, Huang HT, Wu SF, Tseng KC. Clin Interv Aging; 2016 May; 11():1035-41. PubMed ID: 27536084 [Abstract] [Full Text] [Related]
20. The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C. Zayed N, Awad AB, El-Akel W, Doss W, Awad T, Radwan A, Mabrouk M. Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):254-61. PubMed ID: 23141214 [Abstract] [Full Text] [Related] Page: [Next] [New Search]